WEDNESDAY, Dec. 7, 2022 (HealthDay News) — The antiviral Paxlovid has kept people from getting really sick and dying from COVID-19 since it became available — at no cost to them. But by the middle of next year, the U.S. government will stop subsidizing the medication. Instead, it will beContinue Reading
TUESDAY, Dec. 6, 2022 (HealthDay News) — Researchers may have sniffed out why colds are more likely in wintertime: The answer may lie within the nose. A previously unidentified immune response inside the nose is responsible for fighting off the viruses that cause upper respiratory infections, according to researchers atContinue Reading
TUESDAY, Dec. 6, 2022 (HealthDay News) — Experts are asking seniors to get their flu shots ASAP as an exceptionally nasty flu season unfolds across the United States. Already, 8.7 million flu cases have been reported, with 78,000 hospitalizations and 4,500 deaths, according to the U.S. Centers for Disease ControlContinue Reading
MONDAY, Dec. 5, 2022 (HealthDay News) – Mpox cases are down significantly in the United States, prompting the federal government to plan not to renew an emergency designation for the virus when it expires late next month. “Given the low number of cases today, HHS does not expect that itContinue Reading
MONDAY, Dec. 5, 2022 (HealthDay News) – The Laundress, a laundry and cleaning products company, has recalled nearly 8 million of its products over concerns they may be contaminated with various bacteria. The bacteria include Burkholderia cepacia complex, Klebsiella aerogenes and multiple different species of Pseudomonas. So far, testing hasContinue Reading
THURSDAY, Dec. 1, 2022 (HealthDay News) — COVID-19 may harm the liver, a small study suggests. The virus appears to increase liver stiffness, a sign of potential long-term injury, but it’s too early to tell if that portends serious liver disease, the researchers said. “COVID infections have been observed toContinue Reading
THURSDAY, Dec. 1, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved the first fecal microbiota treatment, aimed at helping adults battling tough-to-treat Clostridium difficile (C. diff) infections. “Today’s approval of Rebyota is an advance in caring for patients who have recurrent C. difficile infection [CDI],”Continue Reading
THURSDAY, Dec. 1, 2022 (HealthDay News) — Two common drugs that veterinarians use to kill parasites on pets could be the solution to getting rid of bed bugs. Both fluralaner and ivermectin, which are used to kill fleas and ticks on household pets, could also kill bed bugs. The newer,Continue Reading
THURSDAY, Dec. 1, 2022 (HealthDay News) – U.S. health officials will begin testing wastewater for poliovirus in select locations around the country, including possibly at sites in Michigan and Pennsylvania. The testing will happen in communities that have low polio vaccination rates or those with possible connections to New YorkContinue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual “sick season,” pharmacists report. The antiviral flu drug Tamiflu is in short supply for both adults and children, in both its brandContinue Reading